Clinical Trial Update: Efficacy of add-on Therapy With Vildagliptin in Chinese Patients With Type 2 Diabetes Inadequately Controlled With Prior Metformin Monotherapy [Phase 3]

View source ↗

Summary

This Phase 3 trial assessed the efficacy of adding vildagliptin to metformin in Chinese patients with type 2 diabetes mellitus inadequately controlled on metfor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Vildagliptin (vildagliptin)

Snippet

Sponsor: Novartis | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED